FGF2 and tarsal-carpal coalition syndrome: Several studies have investigated prognostic biomarkers for TCC, such as FGF2 (Shariat et al., 2010), UHRF1 (Unoki et al., 2009), and GRIA1 (Tilley, Kim & Fry, 2017).